{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:54:42Z","timestamp":1792806882270,"version":"4.5.0"},"reference-count":36,"publisher":"American Diabetes Association","issue":"6","license":[{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-16-RHUS-0006_PreciNASH"],"award-info":[{"award-number":["ANR-16-RHUS-0006_PreciNASH"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017228","name":"European Genomic Institute for Diabetes","doi-asserted-by":"publisher","award":["ANR-10-LABX-0046"],"award-info":[{"award-number":["ANR-10-LABX-0046"]}],"id":[{"id":"10.13039\/100017228","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6,1]]},"abstract":"<jats:sec>\n                  <jats:title\/>\n                  <jats:p>The postprandial glucose response is an independent risk factor for type 2 diabetes. Observationally, early glucose response after an oral glucose challenge has been linked to intestinal glucose absorption, largely influenced by the expression of sodium\u2013glucose cotransporter 1 (SGLT1). This study uses Mendelian randomization (MR) to estimate the causal effect of intestinal SGLT1 expression on early glucose response. Involving 1,547 subjects with class II\/III obesity from the Atlas Biologique de l\u2019Ob\u00e9sit\u00e9 S\u00e9v\u00e8re cohort, the study uses SGLT1 genotyping, oral glucose tolerance tests, and jejunal biopsies to measure SGLT1 expression. A loss-of-function SGLT1 haplotype serves as the instrumental variable, with intestinal SGLT1 expression as the exposure and the change in 30-min postload glycemia from fasting glycemia (\u039430 glucose) as the outcome. Results show that 12.8% of the 1,342 genotyped patients carried the SGLT1 loss-of-function haplotype, associated with a mean \u039430 glucose reduction of \u22120.41 mmol\/L and a significant decrease in intestinal SGLT1 expression. The observational study links a 1-SD decrease in SGLT1 expression to a \u039430 glucose reduction of \u22120.097 mmol\/L. MR analysis parallels these findings, associating a statistically significant reduction in genetically instrumented intestinal SGLT1 expression with a \u039430 glucose decrease of \u22120.353. In conclusion, the MR analysis provides genetic evidence that reducing intestinal SGLT1 expression causally lowers early postload glucose response. This finding has a potential translational impact on managing early glucose response to prevent or treat type 2 diabetes<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Article Highlights<\/jats:title>\n               <\/jats:sec>","DOI":"10.2337\/db23-0805","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T16:56:36Z","timestamp":1710780996000},"page":"983-992","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":5,"title":["Genetic Evidence of Causal Relation Between Intestinal Glucose Absorption and Early Postprandial Glucose Response: A Mendelian Randomization Study"],"prefix":"10.2337","volume":"73","author":[{"given":"Simon","family":"Peschard","sequence":"first","affiliation":[{"name":"1European Genomic Institute for Diabetes, University Lille, Lille, France"},{"name":"2U1011 Nuclear Receptors, Metabolic and Cardiovascular Diseases, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5754-2028","authenticated-orcid":false,"given":"Violeta","family":"Raverdy","sequence":"additional","affiliation":[{"name":"1European Genomic Institute for Diabetes, University Lille, Lille, France"},{"name":"3U1190 Translational Research on Diabetes, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France"},{"name":"4Department of General and Endocrine Surgery, CHU Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Bauvin","sequence":"additional","affiliation":[{"name":"1European Genomic Institute for Diabetes, University Lille, Lille, France"},{"name":"3U1190 Translational Research on Diabetes, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Goutchtat","sequence":"additional","affiliation":[{"name":"1European Genomic Institute for Diabetes, University Lille, Lille, France"},{"name":"3U1190 Translational Research on Diabetes, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Touche","sequence":"additional","affiliation":[{"name":"1European Genomic Institute for Diabetes, University Lille, Lille, France"},{"name":"2U1011 Nuclear Receptors, Metabolic and Cardiovascular Diseases, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Derudas","sequence":"additional","affiliation":[{"name":"1European Genomic Institute for Diabetes, University Lille, Lille, France"},{"name":"2U1011 Nuclear Receptors, Metabolic and Cardiovascular Diseases, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Gheeraert","sequence":"additional","affiliation":[{"name":"1European Genomic Institute for Diabetes, University Lille, Lille, France"},{"name":"2U1011 Nuclear Receptors, Metabolic and Cardiovascular Diseases, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Dubois-Chevalier","sequence":"additional","affiliation":[{"name":"1European Genomic Institute for Diabetes, University Lille, Lille, France"},{"name":"2U1011 Nuclear Receptors, Metabolic and Cardiovascular Diseases, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Caiazzo","sequence":"additional","affiliation":[{"name":"1European Genomic Institute for Diabetes, University Lille, Lille, France"},{"name":"3U1190 Translational Research on Diabetes, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France"},{"name":"4Department of General and Endocrine Surgery, CHU Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Baud","sequence":"additional","affiliation":[{"name":"1European Genomic Institute for Diabetes, University Lille, Lille, France"},{"name":"3U1190 Translational Research on Diabetes, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France"},{"name":"4Department of General and Endocrine Surgery, CHU Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Marciniak","sequence":"additional","affiliation":[{"name":"1European Genomic Institute for Diabetes, University Lille, Lille, France"},{"name":"3U1190 Translational Research on Diabetes, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France"},{"name":"4Department of General and Endocrine Surgery, CHU Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Verkindt","sequence":"additional","affiliation":[{"name":"1European Genomic Institute for Diabetes, University Lille, Lille, France"},{"name":"3U1190 Translational Research on Diabetes, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France"},{"name":"4Department of General and Endocrine Surgery, CHU Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naima","family":"Oukhouya Daoud","sequence":"additional","affiliation":[{"name":"1European Genomic Institute for Diabetes, University Lille, Lille, France"},{"name":"3U1190 Translational Research on Diabetes, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France"},{"name":"4Department of General and Endocrine Surgery, CHU Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5521-5445","authenticated-orcid":false,"given":"Carel W.","family":"Le Roux","sequence":"additional","affiliation":[{"name":"5Diabetes Complications Research Centre, University College Dublin, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9366-5129","authenticated-orcid":false,"given":"Philippe","family":"Lefebvre","sequence":"additional","affiliation":[{"name":"1European Genomic Institute for Diabetes, University Lille, Lille, France"},{"name":"2U1011 Nuclear Receptors, Metabolic and Cardiovascular Diseases, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3784-1503","authenticated-orcid":false,"given":"Bart","family":"Staels","sequence":"additional","affiliation":[{"name":"1European Genomic Institute for Diabetes, University Lille, Lille, France"},{"name":"2U1011 Nuclear Receptors, Metabolic and Cardiovascular Diseases, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7839-4757","authenticated-orcid":false,"given":"Sophie","family":"Lestavel","sequence":"additional","affiliation":[{"name":"1European Genomic Institute for Diabetes, University Lille, Lille, France"},{"name":"2U1011 Nuclear Receptors, Metabolic and Cardiovascular Diseases, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Pattou","sequence":"additional","affiliation":[{"name":"1European Genomic Institute for Diabetes, University Lille, Lille, France"},{"name":"3U1190 Translational Research on Diabetes, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France"},{"name":"4Department of General and Endocrine Surgery, CHU Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2024,3,18]]},"reference":[{"key":"2024052018520512000_B1","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/s41591-022-01790-7","article-title":"Heterogeneity in phenotype, disease progression and drug response in type 2 diabetes","volume":"28","author":"Nair","year":"2022","journal-title":"Nat Med"},{"key":"2024052018520512000_B2","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/j.1467-789X.2012.01011.x","article-title":"Impact of postprandial glycaemia on health and prevention of disease","volume":"13","author":"Blaak","year":"2012","journal-title":"Obes Rev"},{"key":"2024052018520512000_B3","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.diabres.2012.08.002","article-title":"Guideline for management of postmeal glucose in diabetes","volume":"103","author":"International Diabetes Federation Guideline Development Group","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"2024052018520512000_B4","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.2337\/dc10-2414","article-title":"Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga Diabetes Study","volume":"34","author":"Cavalot","year":"2011","journal-title":"Diabetes Care"},{"key":"2024052018520512000_B5","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1210\/jc.2018-02166","article-title":"Intestinal glucose absorption is a key determinant of 1-hour postload plasma glucose levels in nondiabetic subjects","volume":"104","author":"Tric\u00f2","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2024052018520512000_B6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.coph.2020.10.017","article-title":"Role of intestinal glucose absorption in glucose tolerance","volume":"55","author":"Wu","year":"2020","journal-title":"Curr Opin Pharmacol"},{"key":"2024052018520512000_B7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S2213-8587(13)70050-0","article-title":"SGLT inhibitors in management of diabetes","volume":"1","author":"Tahrani","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2024052018520512000_B8","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.2337\/dc13-0592","article-title":"Impact of glucose tolerance status, sex, and body size on glucose absorption patterns during OGTTs","volume":"36","author":"F\u00e6rch","year":"2013","journal-title":"Diabetes Care"},{"key":"2024052018520512000_B9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2796.2006.01746.x","article-title":"Active sugar transport in health and disease","volume":"261","author":"Wright","year":"2007","journal-title":"J Intern Med"},{"key":"2024052018520512000_B10","first-page":"G879","article-title":"I. Glucose galactose malabsorption","volume":"275","author":"Wright","year":"1998","journal-title":"Am J Physiol"},{"key":"2024052018520512000_B11","doi-asserted-by":"crossref","first-page":"G241","DOI":"10.1152\/ajpgi.00310.2001","article-title":"Expression of monosaccharide transporters in intestine of diabetic humans","volume":"282","author":"Dyer","year":"2002","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2024052018520512000_B12","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1210\/jc.2017-00348","article-title":"Duodenal sodium\/glucose cotransporter 1 expression under fasting conditions is associated with postload hyperglycemia","volume":"102","author":"Fiorentino","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2024052018520512000_B13","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.cmet.2016.01.018","article-title":"Bile diversion in Roux-en-Y gastric bypass modulates sodium-dependent glucose intestinal uptake","volume":"23","author":"Baud","year":"2016","journal-title":"Cell Metab"},{"key":"2024052018520512000_B14","doi-asserted-by":"crossref","first-page":"106057","DOI":"10.1016\/j.isci.2023.106057","article-title":"Oral metformin transiently lowers post-prandial glucose response by reducing the apical expression of sodium-glucose co-transporter 1 in enterocytes","volume":"26","author":"Zubiaga","year":"2023","journal-title":"iScience"},{"key":"2024052018520512000_B15","doi-asserted-by":"crossref","first-page":"e1235","DOI":"10.1210\/clinem\/dgz258","article-title":"Sotagliflozin decreases postprandial glucose and insulin concentrations by delaying intestinal glucose absorption","volume":"105","author":"Powell","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2024052018520512000_B16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S2213-8587(22)00005-5","article-title":"Data-driven subgroups of type 2 diabetes, metabolic response, and renal risk profile after bariatric surgery: a retrospective cohort study","volume":"10","author":"Raverdy","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2024052018520512000_B17","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/SLA.0000000000001915","article-title":"Incidence and predictive factors of postprandial hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: a five year longitudinal study","volume":"264","author":"Raverdy","year":"2016","journal-title":"Ann Surg"},{"key":"2024052018520512000_B18","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.2337\/dc23-S002","article-title":"2. Classification and diagnosis of diabetes: Standards of Care in Diabetes\u20132023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"2024052018520512000_B19","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1210\/jc.2015-3906","article-title":"Mechanisms of action of liraglutide in patients with type 2 diabetes treated with high-dose insulin","volume":"101","author":"Vanderheiden","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2024052018520512000_B20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1172\/JCI105534","article-title":"Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus","volume":"46","author":"Seltzer","year":"1967","journal-title":"J Clin Invest"},{"key":"2024052018520512000_B21","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/ng1547","article-title":"A genome-wide scalable SNP genotyping assay using microarray technology","volume":"37","author":"Gunderson","year":"2005","journal-title":"Nat Genet"},{"key":"2024052018520512000_B22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nmeth842","article-title":"Whole-genome genotyping with the single-base extension assay","volume":"3","author":"Steemers","year":"2006","journal-title":"Nat Methods"},{"key":"2024052018520512000_B23","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.jacc.2018.07.061","article-title":"Genetic variants in SGLT1, glucose tolerance, and cardiometabolic risk","volume":"72","author":"Seidelmann","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2024052018520512000_B24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12920-019-0536-1","article-title":"Hepatic transcriptomic signatures of statin treatment are associated with impaired glucose homeostasis in severely obese patients","volume":"12","author":"Margerie","year":"2019","journal-title":"BMC Med Genomics"},{"key":"2024052018520512000_B25","doi-asserted-by":"crossref","first-page":"19835","DOI":"10.1038\/s41598-020-76769-w","article-title":"GIANT: galaxy-based tool for interactive analysis of transcriptomic data","volume":"10","author":"Vandel","year":"2020","journal-title":"Sci Rep"},{"key":"2024052018520512000_B26","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"2024052018520512000_B27","doi-asserted-by":"crossref","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"key":"2024052018520512000_B28","first-page":"e34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome","volume-title":"eLife","author":"Hemani","year":"2018"},{"key":"2024052018520512000_B29","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"key":"2024052018520512000_B30","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR Statement","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"2024052018520512000_B31","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E","article-title":"Two-sided confidence intervals for the single proportion: comparison of seven methods","volume":"17","author":"Newcombe","year":"1998","journal-title":"Stat Med"},{"key":"2024052018520512000_B32","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/ng0296-216","article-title":"Defects in Na+\/glucose cotransporter (SGLT1) trafficking and function cause glucose-galactose malabsorption","volume":"12","author":"Mart\u00edn","year":"1996","journal-title":"Nat Genet"},{"key":"2024052018520512000_B33","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1210\/jc.2014-3144","article-title":"Accelerated intestinal glucose absorption in morbidly obese humans: relationship to glucose transporters, incretin hormones, and glycemia","volume":"100","author":"Nguyen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2024052018520512000_B34","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1210\/JC.2015-2482","article-title":"Relationships of early and late glycemic responses with gastric emptying during an oral glucose tolerance test","volume":"100","author":"Marathe","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2024052018520512000_B35","doi-asserted-by":"crossref","first-page":"G946","DOI":"10.1152\/ajpgi.00286.2014","article-title":"Selective sodium-dependent glucose transporter 1 inhibitors block glucose absorption and impair glucose-dependent insulinotropic peptide release","volume":"308","author":"Dobbins","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2024052018520512000_B36","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.cell.2015.11.001","article-title":"Personalized nutrition by prediction of glycemic responses","volume":"163","author":"Zeevi","year":"2015","journal-title":"Cell"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/73\/6\/983\/760867\/db230805.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/73\/6\/983\/760867\/db230805.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T18:53:17Z","timestamp":1716231197000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/73\/6\/983\/154380\/Genetic-Evidence-of-Causal-Relation-Between"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,18]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,3,18]]},"published-print":{"date-parts":[[2024,6,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db23-0805","relation":{},"ISSN":["0012-1797"],"issn-type":[{"value":"0012-1797","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,18]]}}}